|


Lithuanian



....................................
Search
the net
Search.lt
.................................... |
| |
|
Paediatric pulmonology and allergology
|
October, 2002, Vol. V, No.3 (p. 1801-1902)
|
|

Contents:
Ieva
Laimute Indrejaityte, Iveta Skurvydiene, Arunas Valiulis.
Long-term follow up in patients with cystic fibrosis
Edvardas
Danila, Laimute Jurgauskiene, Radvile Malickaite, Remigijus Nargela,
Marija Avizieniene, Regina Aleksoniene, Bronislovas Satkauskas.
Bronchoalveolar lavage for the diagnostics of sarcoidosis
Laimute
Vaideliene, Jurgis Bojarskas. The
importance of bronchial hyperresponsiveness diagnosing bronchial asthma in
chlidhood
Ausra
Kaminskaite. CD4 T lymphocyte count and
the clinical-radiographic presentation of pulmonary tyberculosis
Migle
Klimantaviciene, Arunas Valiulis. Bronchial
response to salbutamol in preschool children with infection related and
non-infection wheezing
Aleksandras
Balbieris, Remigijus Valdemaras Nargela, Arturas Andziulis, Genius
Alfonsas Norvaisas. Quality of life
measurement for patients with asthma St.George's respiratory questionnaire
Danute
Astrauskiene. On Kingella kingae
as an emerging cause of invasive infections in children
Stanislovas
Maknavicius. Mediastinal neurogenic
tumours in children
Albinas
Naudziunas, Skaidrius Miliauskas. Impact
of activatied proein C resistance on the clinical presentation of venous
thromboembolism
Petras
Kaltenis. New aspects of the action of
macrolide antibiotcs (Review article)
Algimantas
Vingras, Danute Skuodyte. Diagnosis of
atypical infection
Global
Initiative for Asthma 2002. Pocket Guide for Asthma Management and
Prevention
|
|
pp.
1804-1811
Long-term
follow up in patients with cystic fibrosis
Ieva
Laimute Indrejaityte, Iveta Skurvydiene, Arunas Valiulis
Cystic fibrosis was recognized over 60 years ago. This
disease was considered to be "fatal" for a long time. During
recent 30 years the length and quality of life patients with CF has
significantly improved. These improvements have resulted not only from the
cellular and molecular biologic discoveries, but form the modern early
diagnostic and more active, effective complex treatment. Mean age of
patients with cystic fibrosis in only approximately 15 years (excluding
adults findings) in Lithuania. Recently, more effective antibiotics,
pancreas enzymes, mucolitics become accessible. The approach to
nourishment of CF patients has also changes. In order to prolong CF
patients lifetime and improve the quality of life it is necessary to
better organize the long-term follow up of patients with CF.
The
authors present particular and long lasting recommendations containing the
experience of the most famous world of CF centers.
Contents |
|
pp.
1812-1816
Bronchoalveolar
lavage for the diagnostics of sarcoidosis
Edvardas
Danila, Laimute Jurgauskiene, Radvile Malickaite, Remigijus Nargela,
Marija Avizieniene, Regina Aleksoniene, Bronislovas Satkauskas
Sarcoidosis
is a multisystem disorder with a heightened cellular immune response at
sited of disease activity in patients with a predisposition for
sarcoidosis and a presumed exposure to as yet unknown transmissible
agents. Aim of the study was to evaluate significance of bronchoalveolar
lavage fluid (BALF) examination in sarcoid patients. Clinical symptoms,
cell differentials and distribution of lymphocyte subgroups in BALF, chest
X-ray, spirometric indices, blood gases in 80 sarcoid patients and 38
healthy volunteers were examined. We founded that lymphocyte percentages
in BAL fluid from sarcoidosis patients were threefold as high as normals
(about 38 perc. compared to 14 perc.). Spontaneous macrophage-lymphocyte
rosettes were found in 63 perc. of these patients. BALF CD4/CD8 ration in
sarcoid patients was 7.2±4.6 as compared to 1.3±0.7 in healthy
volunteers. We concluded that BALF examination may confirm the diagnosis
of sarcoidosis.
Contents |
pp.
1817-1823
The
importance of bronchial hyperresponsiveness diagnosing bronchial asthma in
childhood
Laimute
Vaideliene, Jurgis Bojarskas
Not much is still known about bronchial hyperreactivity in
asthmatic and allergic children. The task of our study was to evaluate the
relationship of bronchial hyperresponsiveness, asthma and other allergic
diseases in childhood. According our results, bronchial
hyperresponsiveness was not found only in 29.0 perc. of children, allergic
to some aeroallergens and having some symptoms of allergy. Even 27.3 perc.
of children had positive bronchial hyperresponsiveness tests, not having
clinical symptoms of obstruction. Positive bronchial hyperresponsiveness
test was found in all 30 children, having asthma symptoms, but asthma was
diagnosed only in 70 perc. of these patients. 70 perc. of children, having
allergic rhinitis symptoms without wheezing, had bronchial
hyperresponsiveness, as well. Bronchial hyperresponsiveness was not
existing in children with atopic dermetitis symptoms only. Our data
showed, that dry cough in children, allergic to some aeroallergens was
related with bronchial hyperresponsiveness more often (80 perc.) in
comparison with non allergic children (50 perc.) and data were
statistically significant.
Contents |
pp.
1824-1830
CD4
T lymphocyte count and the clinical-radiographic presentation of pulmonary
tuberculosis
Ausra
Kaminskaite
The
analysis between radiographic presentation and CD4 T lymphocyte count was
performed after evaluation of blood CD4 T lymphocyte count and CD4/CD8.
The first group included 12 patients (11 males, 1 female, aged 28-45) with
spread cavitary pulmonary tuberculosis: radiographs were evaluated for the
presence of dissemination or infiltration in more than two lobes and
cavities. Tuberculosis for all 12 patients was confirmed by bacteriology.
The second group included 6 patients (males, aged 21-74) with acute
hematogenic generalised tuberculosis: 5 - miliary tuberculosis with signs
of hematogenic pulmonary dissemination, 1 - generalised tuberculous
lymphadenitis without pulmonary changes. Diagnosis of tuberculosis for
them was confirmed by histology. In the first group CD4 T lymphocyte count
in many cases was normal: 580-870/mkl (50 perc. ± 10 perc.); CD4/CD8 -
2.5±0.8. In the second group CD4 T lymphocyte count was significantly
decreased: 103-375/mkl (16.5 perc. ± 9.5 perc.); CD4/CD8 - 0.69±0.5. The
results shows the evidence of the relationship between
clinical-radiographic presentation of pulmonary tuberculosis and CD4 T
lymphocyte count.
Contents |
pp.
1831-1836
Bronchial
response to salbutamol in preschool children with infection related and
non-infection wheezing
Migle
Klimantaviciene, Arunas Valiulis
The
purpose of this study was to compare airway resistance (Rint)
and bronchodilator response of infection related and non-infection
wheezing. Rint was measured before (baseline) and after
salbutamol treatment (postbronchodilator) in 15 children with atopic
asthma and 19 with infection related wheezing bronchitis. Control group
for measure of baseline Rint was recruited of 213 healthy
children. The mean age was 4 (2-6) years. It was found no differences of
mean baseline Rint in all three groups. At the same time
bronchodilator response was significantly higher in asthmatic children
compare with infection related wheezing bronchitis: the mean ratios of
baseline to postsalbutamol measurements was 1.38 (28 perc. change) and
1.17 (15 perc.) respectively. It was confirmed different airway
responsiveness in preschool children with atopic asthma and infection
related wheezing bronchitis.
Contents |
pp.
1837-1845
Quality
of life measurement for patients with asthma St. George's respiratory
questionnaire
Aleksandras
Balbieris, Remigijus Valdemaras Nargela, Arturas Andziulis, Genius
Alfonsas Norvaisas
Quality
of life of 601 patients with bronchial asthma was assessed by St.George
respiratory questionnaire (SGRQ).
SGRQ measures showed QL impairment, which was independent of severity of
disease (95 perc. confidence intervals for TOTAL index 53-55, for SYMPTOMS
64-68, for IMPACT 43-46, for ACTIVITY 60-64).
Addressing the character of impairment, patients indicated that the
SYMPTOMS disturbed their quality of life most of all, the decrease of
ACTIVITY negatively influenced quality of life to a lesser extent, and the
limitations of IMPACT had the least influence.
Correlation of all measures with the main integrated TOTAL index was
confirmed as valid, sufficiently determined and having satisfactory
internal consistency.
SGRQ measures were independent of the following demographic data: age,
gender and the duration of disease.
Contents |
pp.
1846-1854
On
Kingella kingae as an emerging cause of invasive infections in
children
Danute
Astrauskiene
Kingella kingae, the â-hemolytic
gram-negative bacillus was described four decades ago. As a part of
commensal flora of upper respiratory tract it could be isolated in 1 perc.
of children. K.kingae has been given extensive studies in the
recent decade as has been found to cause invasive infections in children
more often than it was thought earlier. It was ascertained that the best
way for isolation of K.kingae is to take material from the tonsilar
surface and to grow on the blood agar medium with the addition of
vancomycin. BACTEC blood culture bottles of BacT/Alert system (Organon
Teknika, USA) media are advised for the isolation of this bacterium from
the synovial fluid. The organism is usually susceptible to ß-lactam
drugs, macrolides, tetracycline, gentamicin, chloramphenicol,
ciprofloxacin, cotrimoxazole and resistant to vancomycin. The damaged
upper respiratory tract mucosa, most often by viral disease, favours
dissemination of K.kingae and the onset of invasive disease. Most
of K.kingae invasive infections are observed in children up to 5
years, with the highest frequency at the age of 6-24 months. Septic
arthiritis and osteomyelitis are the most common clinical presentations
and constitute about three quarters of invasive infections caused by K.kingae.
Other invasive diseases are endocarditis (observed also in school-age
children and adults), meningitis, diseases of lower respiratory tract,
ocular diseases, soft tissue diseases, symptomatic bacteremias. Except for
some cases of endocarditis, invasive K.kingae infections generally
follow a benign clinical course after administration of antibiotic
therapy.
Contents |
pp.
1855-1860
Mediastinal
neurogenic tumours in children
Stanislovas
Maknavicius
In the majority of cases neurological
mediastinal tumours were diagnosed because of increased lymph nodes in the
neck region, decreased activity of the child, pain in the bones and
joints, anemia, bronchitis.
Posterior-anterior and lateral X-ray examination, CT, MRI, sonoscopy,
bronchoscopy and histological examination were used to make the correct
diagnosis. In the period of 1979-2001 we have treated 29 children due to
neurological mediastinal tumours. We had 20 cases of malignant tubours, 9
cases - benign.
Surgery was the main method of diagnosis and treatment. Radical treatment
is impossible in the stages 3 and 4 of the tumour. Treatment consists of
extirpation of the tumour, biopsy of mediastinal or neck region lymph
nodes of histological examination and chemotherapy following the
operation.
Patients with benign neurogenic tumours recovered after the operation.
Contents |
pp.
1861-1869
Impact
of activated protein C resistance on the clinical presentation of venous
thormboembolism
Albinas
Naudziunas, Skaidrius Miliauskas
The aim of the study - to establish incidence of
activated protein C resistance (APC-R) in cases of venous thromboembolism
(VT) and healthy people, to determine influence of APC-R on patients' age,
relapse of VT. Inherited APC-R, as a VT risk factor for those who were ill
with VT was found in 22.1±4.07% cases and 7.1±3.07% for healthy people
(difference of probabilities 0.15). APC-R is a VT risk factor for the
various age people, and not for young patients only: the patients, who had
APC-R, age during the first VT episode was 44.6±17.85 years old, and
those, who didn't have APC-R - 50.4±15.34 years old (t=1.536, p=0.128).
A positive family VT history is not a reliable criterion for selection of
persons who should be examined for inherited APC-R: APC-R was found for
21.0% of patients, which family thrombosis history was positive and for
22.4% of patients, which this history was negative (p>0.05). Inherited
APC-R is not significant factor for VT recurrence. APC-R was found of
28.6% patients with VT recurrence, and 20.5% patients not having the
recurrence (p>0.05). APC-R is a VT risk factor in patients being ill
with the various underlying diseases. No dependence of APC-R and the PE
underlying diseases was found (p of exact X2 criterion
for probability comparison was >0.05).
Contents |
pp.
1870-1875
New
aspects of the action of macrolide antibiotics (Review article)
Petras
Kaltenis
The
aim of this article is to present a short historical review and the newest
data on the influence of macrolide antibiotics on inflammatory reaction
and immune response. It is shown that some macrolides used with
glucocorticoids to treat bronchial asthma lower the need for steroids
(steroid-sparing effect). Most of macrolides act in some way the
metabolism of cytokines, reactive oxygen radicals and other mediators of
inflammatory reaction and immune response. Some data on positive influence
of macorlides in treatment of bronchial asthma, chronic sinusitis and
cystic fibrosis are presented.
Contents |
pp.
1876-1883
Diagnostics
of atypical infection
Algimantas
Vingras, Danute Skuodyte
Atypical infectious agents - M.pneumoniae
and C.pneumoniae become more frequent among the other infectious
agents of upper and lower respiratory tract diseases. Epidemiological
data, clinical symptoms, blood and radiological changes do not allow
reliable differentiation of the causative infectious agent - virus,
bacteria, including atypical. Thus, children with upper and lower
respiratory tract diseases should be investigated for atypical infectious
agents more frequently, especially if disease is of prolonged character.
In the papter clinical symptoms of upper and lower respiratory diseases
caused by M.pneumonia and C.pneumoniae are discussed, as
well as laboratory diagnosis and its interpretation. Enzyme immunoassay
method is preferred for the laboratory diagnosis. Recommendations for
specific IgG and IgM assays are presented.
Contents |
|
|